ISU Abxis Co., Ltd. Logo

ISU Abxis Co., Ltd.

Developing antibody-based immunotherapies for oncology and rare diseases.

086890 | KO

Overview

Corporate Details

ISIN(s):
KR7086890001
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 대왕판교로712번길 22, 씨동 5층 (삼평동, 글로벌알앤디센터), 성남시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

ISU Abxis Co., Ltd. is a biopharmaceutical company that pioneers the discovery and development of engineered antibody-based immunotherapies. The company leverages its advanced antibody technology platform to address significant unmet medical needs in oncology and rare diseases. Its pipeline includes therapeutic candidates such as ISU104 for solid tumors and Fabagal, a treatment for Fabry disease. Founded in 2001, the company is dedicated to developing novel bio-therapeutics to enhance the quality of life for patients with difficult-to-treat conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-08 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-08-22 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.0 MB
2025-08-11 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-08-08 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 14.3 KB
2025-07-21 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 103.4 KB
2025-07-14 00:00
Share Issue/Capital Change
전환청구권행사
Korean 9.4 KB
2025-07-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 26.1 KB
2025-07-11 00:00
Share Issue/Capital Change
전환청구권행사
Korean 14.0 KB
2025-07-08 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-07-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 99.4 KB
2025-06-30 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-06-30 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 107.4 KB
2025-06-24 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-19 00:00
Regulatory News Service
[기재정정]단일판매ㆍ공급계약체결
Korean 18.0 KB

Automate Your Workflow. Get a real-time feed of all ISU Abxis Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ISU Abxis Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ISU Abxis Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Faes Farma S.A. Logo
Develops and markets pharmaceuticals, like antihistamines, and animal nutrition products globally.
Spain
FAE
Fagron N.V. Logo
Supplies compounding ingredients and solutions for personalized medicine to healthcare professionals.
Belgium
FAGR
Farmak Logo
A pharmaceutical manufacturer and exporter of 400+ medicines to over 50 countries.
Ukraine
FARM
Farmsintez ao Logo
Produces APIs & hospital drugs for oncology & specialty diseases; offers contract services.
Russian Federation
LIFE
FATE THERAPEUTICS INC Logo
Develops off-the-shelf iPSC cell therapies for cancer and autoimmune diseases.
United States of America
FATE
FENNEC PHARMACEUTICALS INC. Logo
Prevents chemotherapy-induced hearing loss in children with its sole product, PEDMARK®.
United States of America
FENC
FibroBiologics, Inc. Logo
Clinical-stage biotech developing fibroblast cell therapies for chronic diseases.
United States of America
FBLG
FIBROGEN INC Logo
Biopharma developing first-in-class therapies for cancer, anemia, and serious conditions.
United States of America
FGEN
Fine Foods & Pharmaceuticals Ntm Logo
Contract development & manufacturing of oral solids for pharma, nutraceutical & cosmetic sectors.
Italy
FF
Flora Growth Corp. Logo
A diversified firm in pharma distribution, plant-based wellness, and digital assets.
United States of America
FLGC

Talk to a Data Expert

Have a question? We'll get back to you promptly.